Physician profile
Yun Ling
NPI 1063475341
$6,771.16
in general payments reported to CMS, 2019-2025
48 companies · $1,126 in 2025
The $1,126 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,206 · 2020: $1,024 · 2021: $779 · 2022: $799 · 2023: $823 · 2024: $1,015 · 2025: $1,126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,963.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,078.35 | 2019-2025 | |
| Lilly USA, LLC | $575.83 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astellas Pharma US INC | $521.74 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $491.70 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $425.57 | 2019-2025 | |
| Amgen INC. | $384.87 | 2019-2025 | Evenity, Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $304.74 | 2019-2025 | Jardiance |
| Corcept Therapeutics | $264.30 | 2024-2025 | Korlym |
| Novo Nordisk INC | $242.16 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Nestle Healthcare Nutrition INC. | $197.22 | 2020-2023 | |
| Aimmune Therapeutics, INC. | $191.97 | 2024-2025 | Zenpep |
| Supernus Pharmaceuticals, INC. | $183.14 | 2019-2021 | |
| Allergan, INC. | $172.68 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $166.09 | 2023-2025 | Voquezna |
| Glaxosmithkline, LLC. | $148.71 | 2019-2025 | Shingrix, Arexvy |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $120.05 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $111.18 | 2020-2025 | Capvaxive, Gardasil, Gardasil 9 |
| Abbott Laboratories | $111.02 | 2021-2024 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $99.41 | 2019-2023 | Xarelto |
| Kowa Pharmaceuticals America, INC. | $69.35 | 2019-2023 | Seglentis, Livalo |
| Boston Scientific Corporation | $56.18 | 2020-2025 | Watchman Access System, Wavewriter Alpha Prime 16 |
| Teva Pharmaceuticals USA, INC. | $55.62 | 2019-2021 | |
| Lucid Diagnostics INC. | $49.76 | 2022 | |
| Edwards Lifesciences Corporation | $47.45 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amarin Pharma, INC. | $46.83 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $44.98 | 2019 | |
| Exact Sciences Corporation | $44.16 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $43.21 | 2022-2023 | |
| Sanofi Pasteur INC. | $42.35 | 2019-2025 | |
| Medtronic, INC. | $41.04 | 2025 | Minimed 780g |
| Radius Health, INC. | $40.64 | 2023 | Tymlos |
| Daiichi Sankyo INC. | $38.99 | 2020-2025 | Injectafer |
| E.R. Squibb & Sons, L.L.C. | $38.15 | 2022 | |
| Collegium Pharmaceutical, INC. | $38.14 | 2023-2024 | Xtampza |
| Dexcom, INC. | $37.73 | 2022-2024 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $35.60 | 2025 | Inspire |
| Solventum Corporation | $22.41 | 2025 | Promogran Prisma, Activ.A.C. |
| Lundbeck LLC | $22.16 | 2024 | Rexulti |
| Philips North America LLC | $21.72 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $19.28 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $19.08 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.58 | 2023 | Trulance, Xifaxan |
| Xeris Pharmaceuticals, INC. | $16.78 | 2024 | Gvoke Hypopen |
| Shire North American Group INC | $16.49 | 2019 | |
| Neurelis, INC. | $14.62 | 2023 | Valtoco |
| Arbor Pharmaceuticals, INC. | $14.43 | 2022 | |
| Jazz Pharmaceuticals INC. | $13.40 | 2021 | |
| Eisai INC. | $12.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yun Ling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.